Netherlands
# |
Name |
EBITDA Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
35.04%
|
Dec. 31, 2023 | USD 44.64 | 0.29% |
|
Netherlands |
|
2 |
7.32%
|
Dec. 31, 2023 | USD 36.37 | -0.03% |
|
Netherlands |
|
3 |
5.73%
|
Dec. 31, 2023 | USD 27.61 | 1.08% |
|
Netherlands |
|
4 |
4.03%
|
Dec. 31, 2023 | USD 8.76 | -0.46% |
|
Netherlands |
|
5 |
3.23%
|
Dec. 31, 2023 | USD 127.21 | -1.46% |
|
Netherlands |
|
6 |
-15.68%
|
Dec. 31, 2023 | USD 662.53 | -0.67% |
|
Netherlands |
|
7 |
-350.44%
|
Dec. 31, 2023 | USD 40.94 | -1.52% |
|
Netherlands |
|
8 |
-369.93%
|
Dec. 31, 2023 | USD 2.12 | -1.40% |
|
Netherlands |
|
9 |
-597.09%
|
Dec. 31, 2023 | USD 0.98 | -1.01% |
|
Netherlands |
|
10 |
-1,385.76%
|
Dec. 31, 2023 | USD 22.29 | 2.39% |
|
Netherlands |
|
11 |
-1,597.55%
|
Dec. 31, 2023 | USD 15.74 | -0.32% |
|
Netherlands |
The Healthcare company in Netherlands with the highest EBITDA Margin is Qiagen N.V. (NYSE: QGEN) at 35.04%.
The Healthcare company in Netherlands with the lowest EBITDA Margin is uniQure N.V. (NasdaqGS: QURE) at -1,597.55%.
The top 10 Healthcare companies in Netherlands by EBITDA Margin are Qiagen N.V., Koninklijke Ahold Delhaize N.V., Koninklijke Philips N.V., Pharming Group N.V., Redcare Pharmacy NV, argenx SE, Merus N.V., ProQR Therapeutics N.V., LAVA Therapeutics N.V. and NewAmsterdam Pharma Company N.V..
The bottom 10 Healthcare companies in Netherlands by EBITDA Margin are uniQure N.V., NewAmsterdam Pharma Company N.V., LAVA Therapeutics N.V., ProQR Therapeutics N.V., Merus N.V., argenx SE, Redcare Pharmacy NV, Pharming Group N.V., Koninklijke Philips N.V. and Koninklijke Ahold Delhaize N.V..